New drug guidelines offer hope to Alzheimer's sufferers
Thursday 07 October 2010
Hundreds of thousands of people denied access to Alzheimer's drugs could now get them after a U-turn by the health watchdog, it was announced yesterday. The National Institute for Health and Clinical Excellence (Nice) caused controversy in 2006 and 2007 when it ruled that the medicines would only be available to people in moderate stages of the disease.
Campaigners argued it was "cruel and unethical" to force patients with early-stage Alzheimer's to wait until they became worse before they could get the drugs. Nice's new draft guidance says the medicines should now be made available to people with mild forms of the disease. The guidance, which is subject to appeal, says Aricept (donepezil), Reminyl (galantamine) and Exelon (rivastigmine) will be made available to people with mild as well as moderate Alzheimer's.
It also recommends the use of Ebixa (memantine) for severe disease and for some patients with moderate disease. Previously, it was only on offer to patients as part of a clinical trial.
The drugs, which cost around £2.80 a day, will not cure the disease, but they have been shown to boost everyday functioning, including concentration and alertness, improve mood and restore confidence.
Life & Style blogs
Double chins could be 'cured' without surgery or dieting using new injection
Snapchat got rid of the Best Friends feature and 'stalkers' are upset
Hershey's angers US chocolate purists by forcing company to stop importing 'yummy' Cadbury bars
Food secrets: the good, the bad...and the faeces
Pot of gold: tasting the world’s most expensive tea
- 1 Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
- 2 Mystery man who gave mum heart-warming note on train 'wanted to put a smile on her face'
- 3 Michelle Obama highlights harsh restrictions faced by Saudi women after meeting King Salman without wearing a headscarf
- 4 Mafia's wall of silence broken: Victim of Cosa Nostra's extortion rackets in its Corleone heartland co-operates with authorities for the first time ever
- 5 Amal Clooney gives excellent answer to fashion question at European Court of Human Rights
Negotiable: Tradewind Recruitment: This post arises as a result of the need to...
£120 - £150 per annum: Tradewind Recruitment: I am recruiting on instruction o...
£70000 per annum: Ashdown Group: Head of Finance - Financial Controller - Fina...
£24000 - £28000 per annum + benefits: Ashdown Group: Marketing Executive - Wim...